Newland Pharmaceutical Co., Ltd. (SHE:301277)
14.46
-0.14 (-0.96%)
Last updated: Jul 7, 2025
Newland Pharmaceutical Revenue
Newland Pharmaceutical had revenue of 219.79M CNY in the quarter ending March 31, 2025, with 19.07% growth. This brings the company's revenue in the last twelve months to 761.64M, up 14.80% year-over-year. In the year 2024, Newland Pharmaceutical had annual revenue of 726.44M with 11.51% growth.
Revenue (ttm)
761.64M
Revenue Growth
+14.80%
P/S Ratio
7.51
Revenue / Employee
730.94K
Employees
1,042
Market Cap
5.72B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Sichuan Biokin Pharmaceutical | 5.82B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |